CoChat

Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study

Open access

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; none of the 41 sources its claims cite is checked for support yet.

Abstract

BACKGROUND: Building on the declining trend of malaria in Ethiopia, the Federal Ministry of Health aims to eliminate malaria by 2030. As Plasmodium falciparum and Plasmodium vivax are co-endemic in Ethiopia, the use of primaquine is indicated for both transmission interruption and radical cure, respectively. However, the limited knowledge of the local prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency and its associated variants has hindered the use of primaquine. METHODS: Some 11,138 dried blood spot (DBS) samples were collected in 2011 as part of a national, household Malaria Indicator Survey, a multi-stage nationally representative survey of all malaria-endemic areas of Ethiopia. A randomly selected sub-set of 1414 DBS samples was successfully genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Considering the geographical position and ethnic mix of the country, three common variants: G6PD*A (A376G), G6PD*A- (G202A) and Mediterranean (C563T) were investigated. RESULTS: Of the 1998 randomly selected individuals, 1429 (71.5%) DBS samples were genotyped and merged to the database, of which 53.5% were from females. G6PD*A (A376G) was the only genotype detected. No sample was positive for either G6PD*A- (G202A) or Mediterranean (C563T) variants. The prevalence of G6PD*A (A376G) was 8.9% [95% confidence interval (CI) 6.7-11.2] ranging from 12.2% in the Southern Nations, Nationalities and Peoples' (95% CI 5.7-18.7) to none in Dire Dawa/Harari Region. CONCLUSION: The common G6PD*A- (G202A) or Mediterranean (C563T) variants were not observed in this nationwide study. The observed G6PD*A (A376G) mutation has little or no clinical significance. These findings supported the adoption of primaquine for P. falciparum transmission interruption and radical cure of P. vivax in Ethiopia. As the presence of other clinically important, less common variants cannot be ruled out, the implementation of radical cure will be accompanied by active haematological and adverse events monitoring in Ethiopia.

Overview

CoChat Summary

TL;DR

In a nationally representative 2011 Ethiopian Malaria Indicator Survey sample, the only detected G6PD variant among three screened was G6PD*A (A376G), at 8.9% (95% CI 6.7–11.2), while G6PD*A− (G202A) and Mediterranean (C563T) were absent. These findings supported Ethiopia’s adoption of primaquine for P. falciparum transmission interruption and P. vivax radical cure without prior G6PD testing, with active safety monitoring.

Key findings

  • G6PD*A (A376G) was the only genotype detected: 8.9% (95% CI 6.7–11.2) of analysed samples; 57.8% (75/130) of mutations were in females.
  • No sample was positive for G6PD*A− (G202A) or Mediterranean (C563T).
  • Regional weighted prevalence of G6PD*A (A376G) ranged from 12.2% (95% CI 5.7–18.7) in Southern Nations, Nationalities and Peoples’ to 0 in Dire Dawa/Harari; regional variation was not statistically significant (P = 0.278).
  • Prevalence was 9.2% (95% CI 6.7–11.8) below 2000 m and 7.9% (95% CI 2.4–13.4) at 2000–2500 m (P = 0.403); no spatial clustering was observed.

Methods

  • Cross-sectional analysis of dried blood spot (DBS) samples from the 2011 national Malaria Indicator Survey, a multi-stage, nationally representative household survey of malaria-endemic areas of Ethiopia; 11,138 DBS were collected, and 1998 individuals were randomly selected.
  • Of selected samples, 1429 were genotyped and merged to the database, with 1414 valid genotype results; 53.5% were from females, and mean age was 14.3 years (range 1–89).
  • PCR–RFLP was used to screen for G6PD*A (A376G), G6PD*A− (G202A), and Mediterranean (C563T); weighted prevalence estimates were calculated by region, with 10% of samples genotyped at CDC for quality assurance.

Limitations

  • The paper states a large sample loss (29.2%), mainly because corresponding DBS could not be located, though it suggests little or no systematic bias from this random loss.
  • The study tested only three common variants among hundreds of known G6PD variants, so it cannot definitively conclude that all clinically relevant G6PD-deficient variants are absent in Ethiopians (e.g., G6PD Rehovot), especially in regions with very few samples.
  • The paper states it reports genotypic, not phenotypic, prevalence; no positive controls were used for the Mediterranean (C563T) mutation, and further studies are needed to identify variants underlying phenotypic deficiency reported in some groups.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12936-018-2538-4

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Picture of gel electrophoresis result showing G6PD*A (A376G) mutation. Lane 1 indicates a molecular ladder of 50 bp. Arrows indicate the site for mutation. a Lane A4 and A13 show partial digestion, cut size 308 (undigested), 183 and 125 bp. b Lane B11 show full digestion, cut size 183 and 125 bp
Fig. 1 Picture of gel electrophoresis result showing G6PD*A (A376G) mutation. Lane 1 indicates a molecular ladder of 50 bp. Arrows indicate the site for mutation. a Lane A4 and A13 show partial digestion, cut size 308 (undigested), 183 and 125 bp. b Lane B11 show full digestion, cut size 183 and 125 bpCC BY · PubMed Central
Fig. 2 Spatial distribution of study samples in Ethiopia. a Distribution of samples selected for G6PD genotyping (n = 1947; 51 samples missing GPS coordinates). b Spatial distribution of G6PD*A mutations (n = 130). Darker color depicts higher altitude and lighter color lower altitude. Areas above 2500 m were considered unsuitable for malaria transmission and were not included in the sampling frame. Each dot represents a household where a DBS was collected
Fig. 2 Spatial distribution of study samples in Ethiopia. a Distribution of samples selected for G6PD genotyping (n = 1947; 51 samples missing GPS coordinates). b Spatial distribution of G6PD*A mutations (n = 130). Darker color depicts higher altitude and lighter color lower altitude. Areas above 2500 m were considered unsuitable for malaria transmission and were not included in the sampling frame. Each dot represents a household where a DBS was collectedCC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 19 Not checked · 15 Own results and interpretations

3 more claims

Create a free account to see all 34 claims and to verify the 39 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Cited by

See all 34

Metadata

Authors
Assefa, A., Ali, A., Deressa, W., Tsegaye, W., Abebe, G., Sime, H., Kebede, A., Jima, D., Kassa, M., Abreha, T., Teka, H., Solomon, H., Malone, J., Shi, Y. P., Zhou, Z., Reithinger, R., & Hwang, J.
Affiliations
  • Ethiopian Public Health Institute (ET)
  • Addis Ababa University (ET)
  • Columbia University (US)
  • United States Agency for International Development (US)
  • Federal Ministry of Health (ET)
  • Centers for Disease Control and Prevention (US)
  • RTI International (US)
Corresponding author
Assefa, Ashenafi
Venue
Malaria Journal
Published
2018-10-26
Volume
17
Issue
1
Pages
388-388
ISSN
1475-2875 (ISSN-L)
OpenAlex
W2898115386
Cited by
34
References
27
Citations by year
2026: 9 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 9 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 1
FWCI
1.41
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Malaria Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • United States Agency for International Development
  • Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
glucose-6-phosphate dehydrogenase deficiency, G6PD variants, primaquine, Plasmodium falciparum, Plasmodium vivax, malaria elimination, radical cure, transmission interruption, G6PD prevalence, Ethiopia
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Alleles, Child, Child, Preschool, Ethiopia, Female, Genotype, Glucosephosphate Dehydrogenase Deficiency, Humans, Infant, Male, Middle Aged, Prevalence, Malaria, Falciparum, Malaria, Vivax, Endemic Diseases, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. https://app.cochat.ai/papers/10.1186/s12936-018-2538-4
The paper
Assefa, A., Ali, A., Deressa, W., Tsegaye, W., Abebe, G., Sime, H., Kebede, A., Jima, D., Kassa, M., Abreha, T., Teka, H., Solomon, H., Malone, J., Shi, Y. P., Zhou, Z., Reithinger, R., & Hwang, J. (2018). Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. Malaria Journal. https://doi.org/10.1186/s12936-018-2538-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.